[StemCyte-KY] Announcement of Director Change at Important Subsidiary StemCyte, Inc.
NQ Score
43/100
N1 Content Completeness
10
AI Summary (NQ-processed)
StemCyte-KY announced a change in the board of its important subsidiary, StemCyte, Inc. Director Huang Yen-Chen has stepped down, and Lu Kung-Ming, Vice Chairman of StemCyte Biotech, has been appointed as a new director, effective May 29, 115.
AI Analysis
Frequently Asked Questions
- Q: What is a KY stock in Taiwan?
- A: Companies incorporated in tax havens like Cayman Islands listed on the TWSE.